These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 94296)

  • 41. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 42. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
    Kubo K; Ikeda J; Nakamura J; Nakamizo N
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The inotropic and chronotropic responses of isolated canine atrium to 5-(3-tert.-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol).
    Chiba S
    Arzneimittelforschung; 1979; 29(6):895-7. PubMed ID: 582780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].
    Hapke HJ; Prigge E
    Arzneimittelforschung; 1976; 26(10):1849-57. PubMed ID: 1037204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
    Strosberg AM
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
    Tachikawa S; Takenaka T; Maeno H
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N; Sugawara K; Ozaki M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent.
    Asano M; Uchida W; Shibasaki K; Terai M; Inagaki O; Takenaka T; Matsumoto Y; Fujikura T
    J Pharmacol Exp Ther; 1990 Jul; 254(1):204-11. PubMed ID: 1973196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB; Kennedy I; Levy GP; Marshall RJ
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
    Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
    Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug effects on blood pressure and heart rate in unanesthetized animals. (1). Effects of beta-blocking agents (author's transl)].
    Iizuka H; Nakagawa Y; Matsubara I; Imai S; Yanagita T
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):401-9. PubMed ID: 20392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
    Himori N; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
    Lee RJ; Evans DB; Baky SH; Laffan RJ
    Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.
    Nagatomo T; Tsuchihashi H; Sasaki M; Nakagawa Y; Nakahara H; Imai S
    Jpn J Pharmacol; 1984 Feb; 34(2):249-54. PubMed ID: 6205196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A potent new beta2-adrenoceptor blocking agent.
    Imbs JL; Miesch F; Schwartz J; Velly J; Leclerc G; Mann A; Wermuth CG
    Br J Pharmacol; 1977 Jul; 60(3):357-62. PubMed ID: 19116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
    Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effect of atenolol on the cardiovascular system (author's transl)].
    Izumi T; Nishimura T; Sakai K; Abiko Y; Hattori Y; Nakaya H; Kanno M
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):505-13. PubMed ID: 6110622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
    Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaninolol: a new selective beta 1-adrenoceptor antagonist derived from vanillin.
    Wu BN; Hwang TL; Liao CF; Chen IJ
    Biochem Pharmacol; 1994 Jul; 48(1):101-9. PubMed ID: 8043010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.